RxDoctor Payments Data

Justin Davanzo, MD

Neurological Surgery · Monroeville, PANPI 1114269545

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (41.4%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by MML US, Inc. at 26.6% of the total. 2025 is the largest year on record at $9,299, more than ten times the $673 reported in 2020.

$30,817in general payments, 2019–2025

Across 378 payments — averaging $81.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • MML US, Inc.$8K
  • Medtronic$8K
  • Boston Scientific$7K
  • Abbott$7K
  • Stryker$921
  • Si-bone, Inc.$164
  • plus $713 from 15 others
$842in research payments, 2019–2025

Across 3 payments — averaging $280.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$842

What the payments were for

  • Consulting fees$6,05020%
  • Speaking & faculty fees$9,26330%
  • Travel & lodging$2,7309%
  • Food & beverage$12,75441%
  • Education$200%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,817 in reported general payments places this provider in the 80th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$115,100
Medicare patients
248
Services billed
550

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tizanidine Hcl90$1,042
Gabapentin81$1,024
Methocarbamol22$403
Mupirocin27$178
Cyclobenzaprine Hcl12$97
Meloxicam25$53

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Monroeville

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →